Partner Content Partner Content KOL Mapping and Validation You’ve done your KOL Mapping, and you have been in a therapy area for a while. You may have gotten used to working with the same KOLs and Experts over and over again.
News Japan follows UK in GSK's comeback tour for Blenrep The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
